Budget impact analysis of utilizing canagliflozin (CANA) for the treatment of type 2 diabetes mellitus (T2DM) in an United States health plan

May 1, 2014, 00:00
10.1016/j.jval.2014.03.1417
https://www.valueinhealthjournal.com/article/S1098-3015(14)01468-5/fulltext
Title : Budget impact analysis of utilizing canagliflozin (CANA) for the treatment of type 2 diabetes mellitus (T2DM) in an United States health plan
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01468-5&doi=10.1016/j.jval.2014.03.1417
First page : A243
Section Title : Diabetes/Endocrine Disorders I
Open access? : No
Section Order : 896
Categories :
Tags :
Regions :
ViH Article Tags :